ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
46
views
0
references
Top references
cited by
344
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
4,047
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Epidemiology and Risk Factors of Urothelial Bladder Cancer
Author(s):
Maximilian Burger
,
James Catto
,
Guido Dalbagni
,
H. Grossman
,
Harry Herr
,
Pierre I Karakiewicz
,
Wassim Kassouf
,
Lambertus Kiemeney
,
Carlo La Vecchia
,
Shahrokh François Shariat
,
Yair Lotan
Publication date:
2013-02-01
Journal:
European Urology
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Cancer Metabolism
Author and article information
Journal
DOI::
10.1016/j.eururo.2012.07.033
PubMed ID::
22877502
License:
https://www.elsevier.com/tdm/userlicense/1.0/
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
4,047
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1–3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations
Authors:
Sumanta K. Pal
,
Jonathan E Rosenberg
,
Jean Hoffman-Censits
…
The evolving panorama of HER2-targeted treatments in metastatic urothelial cancer: A systematic review and future perspectives
Authors:
Giorgio Patelli
,
Annalisa Zeppellini
,
Francesco Spina
…
Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2.
Authors:
Stéphane Oudard
,
Stéphane Culine
,
Yann Vano
…
See all similar
Cited by
666
Epidemiology of Bladder Cancer
Authors:
Kalyan Saginala
,
Adam Barsouk
,
John Aluru
…
Guideline of guidelines: non-muscle-invasive bladder cancer
Authors:
Yair Lotan
,
Aditya Bagrodia
,
Solomon L Woldu
The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection
Authors:
Martin C. S. Wong
,
Franklin Fung
,
Colette Leung
…
See all cited by
Version 1
- Current
Version 1